•
Sep 30, 2023

Immuneering Q3 2023 Earnings Report

Total Revenue
$0
Previous year: $38.4K
-100.0%
EPS
-$0.43
Previous year: -$0.49
-12.2%
Gross Profit
-$196K
Previous year: $19K
-1128.4%
Cash and Equivalents
$97.2M
Previous year: $76.4M
+27.3%
Free Cash Flow
-$12.1M
Previous year: -$11M
+9.7%
Total Assets
$114M
Previous year: $134M
-14.8%

Immuneering

Immuneering